KEM - Evang. Huyssens-Stiftung Essen-Huttrop

Essen, North Rhine-Westphalia 45136

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer — Recruiting now